Skip to main content
Download PDF
Download ePub
  • Original investigation
  • Open access
  • Published:

Triglyceride-glucose index trajectory and arterial stiffness: results from Hanzhong Adolescent Hypertension Cohort Study

Cardiovascular Diabetology volume 21, Article number: 33 (2022) Cite this article

Abstract

Background

The triglyceride-glucose index (TyG index) has emerged as a reliable surrogate marker of insulin resistance associated with arterial stiffness. However, most studies were based on a cross-sectional design, and few studies have evaluated the longitudinal impact of the TyG index on arterial stiffness. This study aimed to investigate the associations of single time point measurement and the long-term trajectory of the TyG index with arterial stiffness in a Chinese cohort.

Methods

Data are derived from the Hanzhong Adolescent Hypertension Cohort study. A total of 2480 individuals who participated in the 2017 survey was included in the cross-sectional analysis. A sample of 180 individuals from the sub-cohort with follow-up data in 2005, 2013, and 2017 was enrolled in the longitudinal analysis. The TyG index was calculated as ln (fasting triglyceride [mg/dL] × fasting glucose [mg/dL]/2), and arterial stiffness was determined using brachial-ankle pulse wave velocity (baPWV). The latent class growth mixture modeling method was used to identify the TyG index trajectories from 2005 to 2017.

Results

In the cross-sectional analysis, the median age of the study population was 42.8 (39.8, 44.9) years, and 1351 (54.5%) were males. Each one-unit increment in TyG index was associated with a 37.1 cm/s increase (95% confidence interval [CI] 23.7–50.6 cm/s; P < 0.001) in baPWV, and similar results were observed when the TyG index was in the form of quartiles. In the longitudinal analysis, we identified three distinct TyG index trajectories and found that the highest TyG index trajectory carried the greatest odds of increased arterial stiffness, with a fully adjusted odds ratio (OR) of 2.76 (95% CI 1.40, 7.54).

Conclusions

Elevated levels of baseline TyG index and higher long-term trajectory of TyG index were independently associated with increased arterial stiffness. Monitoring immediate levels and longitudinal trends of the TyG index may help with the prevention of arterial stiffness in the long run.

Background

Arterial stiffness is considered one of the earliest detectable measures of vascular damage, strongly predicting cardiovascular morbidity and mortality [1,2,3]. Previously recognized predisposing factors of arterial stiffness include aging, elevated blood pressure, obesity, diabetes, and metabolic syndrome [4,5,6]. In particular, insulin resistance, a hallmark of obesity and metabolic syndrome, leads to oxidative responses, low-grade inflammation, and endothelial dysfunction, contributing to arterial stiffness progression [7,8,9]. As a surrogate marker of insulin resistance, the triglyceride-glucose (TyG) index, which is calculated as ln [fasting triglycerides (TG, mg/dL) × fasting blood glucose (FBG, mg/dL)/2], has been reported to be associated with cardiovascular risk [10,11,12]. The relationship between the TyG index and arterial stiffness, which is measured using brachial-ankle pulse wave velocity (baPWV), has also been reported. Emerging clinical studies have shown that an elevated TyG index is associated with higher values of baPWV and increased arterial stiffness [13,14,15,16,17]. However, most prior studies are cross-sectional design, and data are still limited regarding the dynamic change of the TyG index over time. Likewise, the associations between long-term TyG index trends and arterial stiffness are largely unknown.

In this study, we aim to investigate the associations between TyG index and arterial stiffness measured using baPWV in the Hanzhong Adolescent Hypertension Cohort Study. In addition, we intended to identify long-term TyG index trajectories and characterize their association with arterial stiffness.

Methods

Study population

The participants were derived from the Hanzhong Adolescent Hypertension Cohort, an ongoing prospective cohort established in 1987 focusing on the natural development of cardiovascular risk factors, which has been described in detail elsewhere [18]. Briefly, in March and April 1987, 4623 schoolchildren aged 6 to 15 years were enrolled from 26 rural sites in Hanzhong, China, and a series of follow-ups were conducted in the following 30 years. In 2005, a subcohort of 436 participants was randomly selected using an isometric sampling method (K = 10) [19,20,21]. In the present study: (1) individuals who participated in the latest examination in 2017 and received the baPWV and laboratory test (N = 2480) were enrolled in the cross-sectional analysis; (2) individuals in the sub-cohort received baPWV test in 2017 with complete FBG and TG data in 2005, 2013 and 2017 (N = 180) were included in the longitudinal analysis. During the selection, individuals who had a history of myocardial infarction, heart failure, stroke, renal failure, or peripheral artery disease were excluded from the analysis (Fig. 1).

Fig. 1
figure 1

Flowchart for inclusion/exclusion of study participants

Full size image

This study was approved by the Ethics Committee of the First Affiliated Hospital of Xi’an Jiaotong University (XJTU1AF2015LSL-047) and was clinically registered (NCT02734472, 12/04/2016). Written informed consent was obtained from all participants.

Characteristics and definition

Demographic characteristics, lifestyle information, use of medicines, and medical history were collected using a standard questionnaire; height, weight, waist circumference, and hip circumference were measured using standardized protocols by trained staff at each visit [20]. Systolic and diastolic blood pressures (SBP, DBP) were measured in the seated position after resting for at least 5 min by experienced technicians using mercury sphygmomanometers or electric devices (Omron M6; Omron, Kyoto, Japan). The average of the three blood pressures readings was used for analysis. Body mass index (BMI) was calculated as the weight (in kilograms) divided by the square of the height in meters (kg/m2). Hypertension was defined as systolic and/ or diastolic blood pressures ≥ 140/90 mmHg or the current use of antihypertensive medications. Diabetes was defined as FBG ≥ 7.0 mmol/L in the cohort exam or self-reporting a history of diabetes diagnosed by physicians. Dyslipidemia was defined as the presence of any one of the following situations: hypertriglyceridemia (TG ≥ 2.26 mmol/L), hypercholesterolemia (TC ≥ 6.22 mmol/L), high levels of low-density lipoprotein cholesterol (LDL-C ≥ 4.14 mmol/L), or low levels of high-density lipoprotein cholesterol (HDL-C < 1.04 mmol/L). Cigarette smoking and alcohol drinking were defined as continuous or cumulative smoking for at least 6 months and consuming alcohol every day and for 6 months. Regular exercise was defined as taking part in physical exercise more than once a week [22].

Biochemical parameters

Fasting blood samples were obtained in the morning, and a range of biochemical parameters was analyzed using an automatic biochemical analyzer (Hitachi 7600; Hitachi, Tokyo, Japan). The biochemical parameters tested included FBG, TC, TG, LDL-C, HDL-C, serum uric acid, serum creatinine, and high-sensitivity C-reactive protein (hs-CRP). TyG index was calculated as ln [fasting triglyceride (mg/dL) × fasting glucose (mg/dL)/2] [17].

BaPWV measurement

Measurement of baPWV was performed using a volume-plethysmographic apparatus (BP-203RPEII; Nihon Colin, Tokyo, Japan), as detailed elsewhere [18, 23]. Briefly, measurements were performed for each participant in a supine position after a 5 min rest, with cuffs wrapped around both sides of the upper arm and ankle, ECG electrodes placed on both wrists, and a heart sound sensor placed on the fourth intercostal space left sternal border. The path distance from the suprasternal notch to the brachium (Lb) or to the ankle on the same side (La), and the time interval between the brachial and ankle waveforms (ΔT) were obtained automatically, and baPWV was calculated as baPWV (cm/s) = (La−Lb)/ ΔT. In this study, the mean value of the right and left baPWV was used for analysis, and a value of baPWV ≥ 1400 cm/s was considered as high-risk baPWV according to the Framingham Risk Score [23, 24].

Statistical methods

Participants’ characteristics were described according to the quartile groups of the TyG index in the cross-sectional analysis, and according to the TyG index trajectories in the longitudinal analysis. Data were presented as the mean ± standard deviation, the medians with interquartile ranges, and frequencies or percentages where applicable. Linear trends in characteristics among groups were investigated using one-way ANOVA for linear trends and the Jonckheere-Terpstra test for continuous variables with normal and skewed distributions, and using the chi-square test for linear trend (Cochran–Armitage trend test) for categorical variables. Differences in baPWV values across quartiles were tested using Kruskal–Wallis test and post hoc test. The dose–response relationship between the TyG index and baPWV in the cross-sectional analysis was explored using restricted cubic regression with three knots located at percentiles (10th, 50th, and 90th) of the TyG index. The median of the TyG index was used as the reference point [17]. Multivariate linear regression models were used to estimate the associations of the TyG index with baPWV values in the cross-sectional analysis, with confounding variables selected based on previous literature and clinical knowledge [13, 17]. Several models were fitted on unadjusted analyses to determine the association between arterial stiffness and the TyG index according to prior published literature [13]. The long-term TyG index trajectories were identified using the latent class growth mixture modeling method [20]. Participants with similar patterns of change in the TyG index from 2005 to 2017 were identified and assigned to corresponding groups. Models were fitted using the LCMM package (version 1.8.1) in R (version 3.6.1, Vienna, Austria). The optimal shape of trajectories (intercept, linear, or quadratic) and the number of groups (starting with 2-group) were determined by: (1) higher Bayesian information criterion, (2) at least 5% of the total membership in each trajectory, (3) higher mean posterior probabilities (> 0.7) [25, 26]. Finally, 3 distinct trajectories turned out to be the best-fitting model. The associations of the TyG index with baPWV values in the cross-sectional and the longitudinal analysis were estimated using multivariate linear regression models and the logistic regression models, respectively. Logistic regression models were utilized to investigate the associations between TyG index trajectory and arterial stiffness, with candidate variables selected using stepwise selection methods. To assess the robustness of the associations between TyG index trajectories and arterial stiffness, we also conducted a sensitivity analysis by excluding participants who were on any antihypertensive, antidiabetic, or lipid-lowering medications. All analyses were conducted in R and SPSS software (version 22.0, SPSS Inc., Chicago, IL). A two-sided P value < 0.05 was considered statistically significant.

Results

Characteristics of the study participants in the cross-sectional analysis

Among the 2480 eligible participants, the median age was 42.8 (39.8, 44.9) years, and 1351 (54.5%) were males. The median TyG index was 8.5 (8.1, 8.9), and the median baPWV was 1215.5 (1091.5, 1373.0) cm/s. Participants were stratified into four groups on the basis of the TyG index levels (Table 1). Compared to those in the lowest TyG index quartile, participants in the higher quartiles were more often to be men, smokers, drinkers, and had a higher prevalence of hypertension, diabetes, and dyslipidemia. In addition, BMI, heart rate, SBP, DBP, waist/hip ratio, FBG, TC, TG, LDL-C, serum uric acid, serum creatinine, and hs-CRP level were all positively correlated with increasing TyG index quartiles, while HDL-C was negatively correlated (all P for trend < 0.05).

Table 1 Characteristics of participants according to quartiles of TyG index in 2017 (n = 2480)
Full size table

Association of the TyG index with baPWV

The mean baPWV values increased with increasing quartiles of the TyG index (P < 0.05, Fig. 2a). Overall, baPWV was positively associated with the TyG index (Fig. 2b). For linear regression models measuring TyG index as a continuous variable, each one-unit increment in TyG index was associated with a 37.1 cm/s increase (95% CI, 23.7–50.6 cm/s; P < 0.05) in baPWV, after adjustment for age, sex, smoking, alcohol drinking, regular activity, BMI, hs-CRP, SBP, and diabetes status (Table 2). Likewise, the categorical analysis revealed that compared with those in the lowest quartile of TyG index, the third and highest quartile of TyG index were significantly associated with a 38.4 cm/s (95% CI 17.2–59.7 cm/s; P < 0.05) and 67.3 (95% CI 42.8–91.8 cm/s; P < 0.05) increase in baPWV after adjusting for all covariates, respectively.

Fig. 2
figure 2

Comparison of the baPWV levels among the TyG index quartiles (a) and the associations of the TyG index with baPWV (b). a Differences in baPWV values across quartiles were tested using Kruskal–Wallis test and post hoc test. *P < 0.05 versus the first quartile; #P < 0.05 versus the second quartile; &P < 0.05 versus the third quartile. b Data were fitted with a linear regression model using restricted cubic splines with 3 knots at 10, 50, and 90th percentiles of TyG index. The model was adjusted for age, sex, smoking, drinking, regular exercise, SBP, BMI, hs-CRP, and diabetes. The solid line represented the estimations, and the shaded area represented 95% confidence interval

Full size image
Table 2 Association of TyG index with baPWV in 2017 (n = 2480)
Full size table

Baseline characteristics of the study participants in the longitudinal study

Among 180 participants included in the longitudinal analysis, the median age was 28.7 (27.1–32.2) years at baseline, and 108 (60.0%) were men. Over the 12-year observation period, three distinct TyG index trajectories were identified: low-stable (n = 63, 35.0%) moderate (n = 46, 25.6%), and high-increasing (n = 71, 39.4%; Fig. 3) TyG index trajectory groups. At baseline, the TyG index levels for each dynamic trajectory group were 8.2 ± 0.4, 8.5 ± 0.2, and 8.8 ± 0.5, respectively (Table 3). Compared with the low-stable group, participants in the moderate and high-increasing groups tended to be males, had higher BMI and waist/ hip ratio, and had higher blood pressures, FBG, TC, TG, LDL-C, and TyG index (all P for trend < 0.05). No significant difference was observed in age, HDL-C level, hs-CRP, and prevalence of hypertension and dyslipidemia among the three groups. No participant was found with diabetes at baseline. A comparison of characteristics of study participants in survey 2017 among the three trajectory groups is presented in Additional file 1: Table S1. Significant differences were observed in lifestyles, anthropometric parameters, medical history, and laboratory indices. Notably, participants in the high-increasing groups were more likely to have higher TyG index levels and baPWV values relative to their counterparts in the low-stable group (P for trend < 0.05). The median changes in TyG index level over the 12 years were 0.06 (− 0.10 to 0.25) in the low-stable group, -0.15 (− 0.28 to 0.04) in the moderate group, and 0.28 (− 0.14 to 0.67) in the high-increasing trajectory group.

Fig. 3
figure 3

TyG index trajectory over a 12-year follow-up

Full size image
Table 3 Baseline characteristics of participants in 2005 according to TyG index trajectory (n = 180)
Full size table

Association of TyG index trends with arterial stiffness

Among the 180 participants, 39 (21.7%) had increased baPWV in 2017. The incident rate presented an increasing trend, which was 7 (11.1%), 11 (23.4%), and 21 (30.0%) in the low-stable, moderate, and high-increasing trajectory groups, respectively. The association between the TyG index trajectories and increased arterial stiffness is presented in Table 4. Taking the low-stable group as a reference, participants in the high-increasing group had over 3.3 times the odds of arterial stiffness (OR = 3.32 (1.24–8.90); P = 0.017), based on age-sex-adjusted multivariable logistic regression analysis. This relationship remained statistically significant after further adjustment for regular exercise and hypertension. Participants in the moderate group showed a comparable probability of arterial stiffness to those in the low-stable group (OR = 2.39 (0.85–6.77); P = 0.10), and further adjustments produced similar results.

Table 4 Association of TyG index trajectories with high-risk baPWV in 12-year follow-ups
Full size table

Sensitivity analysis

Excluding participants who were receiving antihypertensive, antidiabetic, or lipid-lowering treatments (n = 22) did not lead to substantial changes to the results (Additional file 2: Table S2). Interestingly, excluding participants with active treatments strengthened the association between TyG index trajectories with arterial stiffness; relative to the low-stable group, the high-increasing group had the highest odds for arterial stiffness (OR = 3.57 (1.45, 9.63), P = 0.037), and the moderate group showed a borderline significant association with arterial stiffness (OR = 3.54 (1.00, 9.59), P = 0.051) after adjustment for various confounders.

Discussion

In the present study, we observed a significant association between the TyG index and baPWV as a measurement of arterial stiffness in the general population. In cross-sectional settings, the TyG index positively correlated with baPWV in both continuous variables and quartiles form. Furthermore, during a 12-year observation period, 3 heterogeneous patterns of TyG index trajectory were identified, with the high-increasing trajectory carrying the greatest odds of increased arterial stiffness. These findings suggest that high levels of insulin resistance, as well as long-term exposure to high insulin resistance, may play a role in the pathogenesis of arterial stiffness.

TyG index is a surrogate marker of insulin resistance deemed to provide better predictive performance in cardiovascular disease. Mounting evidence from cohort studies has confirmed the elevated TyG index to be a reliable predictor of adverse cardiovascular events [10,11,12, 27,28,29,30]. As of late, the association between the TyG index and arterial stiffness has gained increasing attention. Lee et al. demonstrated that elevated TyG index independently associated with increased arterial stiffness as measured by baPWV in the Korean general population [13]. Likewise, Guo et al. reported the TyG index to be an independent risk factor for high baPWV among Chinese healthy individuals [15]. Emerging evidence also suggested that the TyG index was positively and independently associated with baPWV in older adults, diabetics, and hypertensive patients [14, 16, 31, 32]. Additionally, Wu et al. reported a longitudinal relationship between the baseline TyG index and arterial stiffness progression in the Kailuan cohort, indicating that a higher TyG index predicted a higher risk and faster progression of arterial stiffness [17]. Despite the abundance of evidence for a cross-sectional association between the TyG index and baPWV, our investigation has a few differences from previous studies. One of the most notable differences is the population composition. Our study consisted of participants from a population-based cohort, with diverse socio-economic characteristics [13, 15, 17]. Another difference is that the individuals included in this study were relatively young, with a mean age of 42 years. Middle adulthood (age 40 to 65 years) is the time where cardiovascular profile rapidly changes, and is also an important life stage for early detection and intervention of cardiovascular risk. With these points in mind, our study based on a general population suggests that the TyG index can also function as a useful early indicator of arterial stiffness and thus reflects cardiovascular risk in early middle age. Previous studies were mainly focused on the TyG index measured at a single time point, which may not capture long-term exposure. Considering the dynamic changes in TG, FBG, and therefore TyG index over time, the impact of longitudinal TyG index trends needs to be evaluated. In a recent study, Gao et al. observed 4 distinct trajectories of the TyG index over 20 years, each associated with a different risk of future peripheral artery disease, with the two-decade trajectory with an elevated TyG index presenting the greatest risk [33]. However, little is known about the longitudinal variation of the TyG index and its association with subsequent arterial stiffness. Consistent with previous studies, our findings confirmed a significant cross-sectional association of the TyG index with baPWV. Importantly, we expanded previous observations by identifying distinct TyG index trajectories from early to middle adulthood. To the best of our knowledge, this is the first report concerning the impact of long-term TyG index trajectory on the progression of arterial stiffness in the general population. We highlighted the fact that the TyG index could fluctuate over time, and a single time point measurement cannot fully reflect the heterogeneous patterns of trends. Long-term trajectories of the TyG index provide additional information about the cumulative burden of risk for arterial stiffness. Our findings further suggested that participants with consistently higher TyG index (mean TyG index > 8.8) from early to middle adulthood were more susceptible to increased arterial stiffness after adjustment for traditional risk factors. In clinical practice, such individuals require early and intensive screening and management of risk factors to prevent arterial stiffness and, consequently, cardiovascular events.

Although the underlying mechanisms accounting for the associations between the TyG index and arterial stiffness have not been fully elucidated, it appears to be related to insulin resistance. The insulin signaling pathway could be disturbed by insulin resistance, leading to oxidative stress and impaired endothelial function at the intima cells level, including endothelial cells, smooth muscle cells, and macrophages. Furthermore, insulin action could also be impaired by insulin resistance, promoting chronic low-grade inflammation and dysregulation of glucose homeostasis [34,35,36]. These processes contribute to the development of arterial stiffness. Our results also confirmed previous findings that participants with high TyG index quartiles showed higher hs-CRP levels, a sensitive marker of inflammation, suggesting inflammation may be involved in the interplay between insulin resistance and arterial stiffness [17]. In 2008, Simental-Mendía et al. firstly introduced the TyG index as a surrogate to identify insulin resistance in apparently healthy subjects [37]. Growing evidence suggests that the TyG index performs better for assessing insulin resistance and is better associated with CVD and arterial stiffness than the homeostasis model assessment for insulin resistance (HOMA-IR), which is a traditional and the most frequently used marker of insulin resistance [13, 31, 38,39,40,41]. The molecular mechanisms of the TyG index as an effective marker of insulin resistance have not been completely understood, but it may be related to impaired metabolic flexibility. Insulin resistance disrupts insulin-mediated suppression of glucose production, and perturbs fatty acid metabolism during accumulation of skeletal muscle triglyceride [42, 43]. Nevertheless, the underlying mechanisms still warrant further investigation at the pathway levels.

Our study also has several limitations that need to be acknowledged. First, the study population was restricted to northern Chinese individuals, limiting the generalizability of the findings. Second, the follow-ups were unequally spaced in time, resulting in a shortage of data from 2005 to 2013. Third, the sample of participants in the longitudinal analysis was relatively small, leading to the less precise estimation of the parameters, which was reflected as wide confidence intervals for ORs. And during the long-term follow-up, there is a loss of participants. However, baseline characteristics in 2005 were similar between the participants and non-participants, and the study cohort seems to be representative of the original study population (see Additional file 3: Table S3, Additional file 4: Table S4). Additionally, participants included in this study were relatively young, with the oldest being 45 years old at the latest follow-up, and the number of participants with high baPWV was rather small. Large-scale prospective population studies are required to further understand and confirm the conclusions. Despite these limitations, this is the first study to demonstrate the association between TyG index trajectories and arterial stiffness. The combination of cross-sectional and longitudinal analyses provides a comprehensive insight into this association.

Conclusions

Participants with elevated levels of baseline TyG index and higher long-term trajectory of TyG index were more likely to have a higher risk of arterial stiffness. These findings emphasize the importance of long-term TyG index patterns in the evolution of arterial stiffness and may help with the early detection of high-risk individuals.

Availability of data and materials

The derived data generated in the current study are available from the corresponding author, upon reasonable request.

References

  1. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55(13):1318–27.

    PubMed  Google Scholar 

  2. Mitchell GF, Hwang S-J, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, Vita JA, Levy D, Benjamin EJ. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation. 2010;121(4):505–11.

    PubMed  PubMed Central  Google Scholar 

  3. Ohkuma T, Ninomiya T, Tomiyama H, Kario K, Hoshide S, Kita Y, et al. Brachial-ankle pulse wave velocity and the risk prediction of cardiovascular disease: an individual participant data meta-analysis. Hypertension. 2017;69(6):1045–52.

    CAS  PubMed  Google Scholar 

  4. Safar ME. Arterial stiffness as a risk factor for clinical hypertension. Nat Rev Cardiol. 2018. https://doi.org/10.1038/nrcardio.2017.155.

    Article  PubMed  Google Scholar 

  5. Mitchell GF. Arterial stiffness in aging: does it have a place in clinical practice? Recent advances in hypertension. Hypertension. 2021;77(3):768–80.

    CAS  PubMed  Google Scholar 

  6. Sequí-Domínguez I, Cavero-Redondo I, Álvarez-Bueno C, Saz-Lara A, Mesas AE, Martínez-Vizcaíno V. Association between arterial stiffness and the clustering of metabolic syndrome risk factors: a systematic review and meta-analysis. J Hypertens. 2021;39(6):1051–9.

    PubMed  Google Scholar 

  7. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116(7):1793–801.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Glass CK, Olefsky JM. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 2012;15(5):635–45.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Yaribeygi H, Farrokhi FR, Butler AE, Sahebkar A. Insulin resistance: review of the underlying molecular mechanisms. J Cell Physiol. 2019;234(6):8152–61.

    CAS  PubMed  Google Scholar 

  10. Barzegar N, Tohidi M, Hasheminia M, Azizi F, Hadaegh F. The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: tehran lipid and glucose study. Cardiovasc Diabetol. 2020;19(1):155.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Hong S, Han K, Park C-Y. The triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease: a population-based study. BMC Med. 2020;18(1):361.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Wang A, Wang G, Liu Q, Zuo Y, Chen S, Tao B, et al. Triglyceride-glucose index and the risk of stroke and its subtypes in the general population: an 11-year follow-up. Cardiovasc Diabetol. 2021;20(1):46.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Lee SB, Ahn CW, Lee BK, Kang S, Nam JS, You JH, Kim MJ, Kim MK, Park JS. Association between triglyceride glucose index and arterial stiffness in Korean adults. Cardiovasc Diabetol. 2018;17(1):41.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Li M, Zhan A, Huang X, Hu L, Zhou W, Wang T, Zhu L, Bao H, Cheng X. Positive association between triglyceride glucose index and arterial stiffness in hypertensive patients: the China H-type Hypertension Registry Study. Cardiovasc Diabetol. 2020;19(1):139.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Guo W, Zhu W, Wu J, Li X, Lu J, Qin P, Zhu C, Xu N, Zhang Q. Triglyceride glucose index is associated with arterial stiffness and 10-year cardiovascular disease risk in a Chinese population. Front Cardiovasc Med. 2021;8: 585776.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Su Y, Wang S, Sun J, Zhang Y, Ma S, Li M, et al. Triglyceride glucose index associated with arterial stiffness in Chinese community-dwelling elderly. Front Cardiovasc Med. 2021;8: 737899.

    PubMed  PubMed Central  Google Scholar 

  17. Wu S, Xu L, Wu M, Chen S, Wang Y, Tian Y. Association between triglyceride-glucose index and risk of arterial stiffness: a cohort study. Cardiovasc Diabetol. 2021;20(1):146.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Chu C, Dai Y, Mu J, Yang R, Wang M, Yang J, et al. Associations of risk factors in childhood with arterial stiffness 26 years later: the Hanzhong adolescent hypertension cohort. J Hypertens. 2017;35(Suppl 1):S10–5.

    CAS  PubMed  Google Scholar 

  19. Zheng W, Mu J, Chu C, Hu J, Yan Y, Ma Q, et al. Association of blood pressure trajectories in early life with subclinical renal damage in middle age. J Am Soc Nephrol. 2018;29(12):2835–46.

    PubMed  PubMed Central  Google Scholar 

  20. Yan Y, Zheng W, Ma Q, Chu C, Hu J, Wang K, et al. Child-to-adult body mass index trajectories and the risk of subclinical renal damage in middle age. Int J Obes (Lond). 2021;45(5):1095–104.

    Google Scholar 

  21. Taherdoost H. Sampling methods in research methodology; how to choose a sampling technique for research. Int J Acad Res Manag. 2016. https://doi.org/10.2139/ssrn.3205035.

    Article  Google Scholar 

  22. Yan Y, Ma Q, Liao Y, Chen C, Hu J, Zheng W, et al. Blood pressure and long-term subclinical cardiovascular outcomes in low-risk young adults: insights from Hanzhong adolescent hypertension cohort. J Clin Hypertens (Greenwich). 2021;23(5):1020–9.

    Google Scholar 

  23. Wang Y, Yuan Y, Gao W-H, Yan Y, Wang K-K, Qu P-F, et al. Predictors for progressions of brachial-ankle pulse wave velocity and carotid intima-media thickness over a 12-year follow-up: Hanzhong Adolescent Hypertension Study. J Hypertens. 2019;37(6):1167–75.

    CAS  PubMed  Google Scholar 

  24. Yuan Y, Mu J-J, Chu C, Zheng W-L, Wang Y, Hu J-W, et al. Effect of metabolically healthy obesity on the development of arterial stiffness: a prospective cohort study. Nutr Metab (Lond). 2020;17:50.

    CAS  Google Scholar 

  25. Joo YS, Kim HW, Nam KH, Young Lee J, Chang TI, Park JT, et al. Association between longitudinal blood pressure trajectory and the progression of chronic kidney disease: results from the KNOW-CKD. Hypertension. 2021;78(5):1355–64.

    CAS  PubMed  Google Scholar 

  26. Zheng X, Peng Y, Zhong C, Xie X, Wang A, Zhu Z, et al. Systolic blood pressure trajectories after discharge and long-term clinical outcomes of ischemic stroke. Hypertension. 2021;77(5):1694–702.

    CAS  PubMed  Google Scholar 

  27. Sánchez-Íñigo L, Navarro-González D, Fernández-Montero A, Pastrana-Delgado J, Martínez JA. The TyG index may predict the development of cardiovascular events. Eur J Clin Invest. 2016;46(2):189–97.

    PubMed  Google Scholar 

  28. Wang A, Tian X, Zuo Y, Chen S, Meng X, Wu S, Wang Y. Change in triglyceride-glucose index predicts the risk of cardiovascular disease in the general population: a prospective cohort study. Cardiovasc Diabetol. 2021;20(1):113.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Ding X, Wang X, Wu J, Zhang M, Cui M. Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol. 2021;20(1):76.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Tian X, Zuo Y, Chen S, Liu Q, Tao B, Wu S, Wang A. Triglyceride-glucose index is associated with the risk of myocardial infarction: an 11-year prospective study in the Kailuan cohort. Cardiovasc Diabetol. 2021;20(1):19.

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Wang S, Shi J, Peng Y, Fang Q, Mu Q, Gu W, Hong J, Zhang Y, Wang W. Stronger association of triglyceride glucose index than the HOMA-IR with arterial stiffness in patients with type 2 diabetes: a real-world single-centre study. Cardiovasc Diabetol. 2021;20(1):82.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Wu Z, Zhou D, Liu Y, Li Z, Wang J, Han Z, et al. Association of TyG index and TG/HDL-C ratio with arterial stiffness progression in a non-normotensive population. Cardiovasc Diabetol. 2021;20(1):134.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Gao J-W, Hao Q-Y, Gao M, Zhang K, Li X-Z, Wang J-F, Vuitton DA, Zhang S-L, Liu P-M. Triglyceride-glucose index in the development of peripheral artery disease: findings from the Atherosclerosis Risk in Communities (ARIC) Study. Cardiovasc Diabetol. 2021;20(1):126.

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, Sowers JR. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119: 154766.

    CAS  PubMed  Google Scholar 

  35. Rehman K, Akash MSH. Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked? J Biomed Sci. 2016;23(1):87.

    PubMed  PubMed Central  Google Scholar 

  36. Vlachopoulos C, Dima I, Aznaouridis K, Vasiliadou C, Ioakeimidis N, Aggeli C, Toutouza M, Stefanadis C. Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation. 2005;112(14):2193–200.

    PubMed  Google Scholar 

  37. Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304.

    PubMed  Google Scholar 

  38. Sánchez-García A, Rodríguez-Gutiérrez R, Mancillas-Adame L, González-Nava V, Díaz González-Colmenero A, Solis RC, Álvarez-Villalobos NA, González-González JG. Diagnostic accuracy of the triglyceride and glucose index for insulin resistance: a systematic review. Int J Endocrinol. 2020;2020:4678526.

    PubMed  PubMed Central  Google Scholar 

  39. Irace C, Carallo C, Scavelli FB, De Franceschi MS, Esposito T, Tripolino C, Gnasso A. Markers of insulin resistance and carotid atherosclerosis. A comparison of the homeostasis model assessment and triglyceride glucose index. Int J Clin Pract. 2013;67(7):665–72.

    CAS  PubMed  Google Scholar 

  40. Zhao Q, Cheng Y-J, Xu Y-K, Zhao Z-W, Liu C, Sun T-N, Zhou Y-J. Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus. Cardiovasc Diabetol. 2021;20(1):190.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Bornfeldt KE, Tabas I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab. 2011;14(5):575–85.

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Goodpaster BH, Sparks LM. Metabolic flexibility in health and disease. Cell Metab. 2017;25(5):1027–36.

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Kelley DE, Goodpaster BH. Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance. Diabetes Care. 2001;24(5):933–41.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank the Cardiovascular Research Institute of Hanzhong People’s Hospital for assistance with the data collection.

Funding

This work was supported by the National Natural Science Foundation of China No. 82070437(J.-J.M.) and No. 81870319 (J.-J.M.), the Clinical Research Award of the First Affiliated Hospital of Xi’an Jiaotong University (XJTU1AF-CRF-2019-004).

Author information

Authors and Affiliations

  1. Department of Cardiology, First Affiliated Hospital of Medical School, Key Laboratory of Molecular Cardiology of Shaanxi Province, Ministry of Education, Xi’an Jiaotong University, Key Laboratory of Environment and Genes Related to Diseases (Xi’an Jiaotong University), NO.277, Yanta West Road, Xi’an, 710061, Shaanxi, People’s Republic of China

    Yu Yan, Dan Wang, Yue Sun, Qiong Ma, Keke Wang, Yueyuan Liao, Chen Chen, Hao Jia, Chao Chu, Wenling Zheng, Yang Wang, Yuliang Wu & Jianjun Mu

  2. Department of Cardiovascular Surgery, First Affiliated Hospital of Medical School, Xi’an Jiaotong University, Xi’an, China

    Jiawen Hu

  3. Department of Cardiovascular Medicine, Jiangsu Province Hospital, Nanjing, China

    Yue Yuan

Authors
  1. Yu Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yue Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qiong Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Keke Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yueyuan Liao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Chen Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hao Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Chao Chu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Wenling Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Jiawen Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Yue Yuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Yang Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Yuliang Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Jianjun Mu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

YY, YLW, and JJM contributed to the conception and design of the study. YY, DW, YS, QM, KKW, YYL, CC, HJ, CC, WLZ, JWH, YY, and YW contributed to the data acquisition, analysis, and interpretation of the work. YY and JJM drafted and revised the manuscript. All authors have read and approved the final manuscript.

Corresponding authors

Correspondence to Yuliang Wu or Jianjun Mu.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Ethics Committee of the First Affiliated Hospital of Xi’an Jiaotong University. Written informed consent was obtained from all participants.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1:

Table S1. Characteristics of participants in 2017 according to TyG index trajectory (n=180).

Additional file 2:

Table S2. Association of TyG index trajectories with high-risk baPWV in 12-year follow-ups (sensitivity analysis).

Additional file 3:

Table S3. Comparison of characteristics in 1987 between participants and non-participants in the cross-sectional study.

Additional file 4:

Table S4. Comparison of characteristics in 2005 between participants and non-participants in the longitudinal study.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yan, Y., Wang, D., Sun, Y. et al. Triglyceride-glucose index trajectory and arterial stiffness: results from Hanzhong Adolescent Hypertension Cohort Study. Cardiovasc Diabetol 21, 33 (2022). https://doi.org/10.1186/s12933-022-01453-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12933-022-01453-4

Keywords

Cardiovascular Diabetology

ISSN: 1475-2840